Clinical Trial Update: Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for mycophenolate in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• MycoPhenolate (mycophenolate mofetil)

Snippet

Sponsor: University College, London | Conditions: Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis | Phase 2 | Status: UNKNOWN